Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$4.82 - $9.15 $1.21 Million - $2.3 Million
-251,400 Reduced 99.02%
2,500 $15,000
Q1 2024

May 13, 2024

BUY
$3.23 - $6.17 $17,765 - $33,935
5,500 Added 2.21%
253,900 $1.36 Million
Q4 2023

Feb 08, 2024

BUY
$1.25 - $5.21 $250,625 - $1.04 Million
200,500 Added 418.58%
248,400 $1.25 Million
Q3 2023

Nov 01, 2023

BUY
$1.29 - $3.1 $61,791 - $148,490
47,900 New
47,900 $80,000
Q1 2023

Jun 13, 2024

SELL
$1.35 - $4.78 $211,140 - $747,592
-156,400 Reduced 61.6%
97,500 $177,000
Q4 2022

Feb 01, 2023

BUY
$4.35 - $6.77 $1,305 - $2,030
300 Added 0.31%
97,500 $494,000
Q3 2022

Nov 10, 2022

BUY
$3.65 - $6.43 $354,780 - $624,996
97,200 New
97,200 $515,000

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $2.17B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.